77 related articles for article (PubMed ID: 26114190)
1. Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease.
Gross S; Adriaanse MP; Nijeboer P; Tack GJ; van Hoogstraten IM; Bouma G; Mulder CJ; von Blomberg BM; Vreugdenhil AC; Bontkes HJ
J Gastrointestin Liver Dis; 2015 Jun; 24(2):258-9. PubMed ID: 26114190
[No Abstract] [Full Text] [Related]
2. Additional value of serum I-FABP levels for evaluating celiac disease activity in children.
Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA
Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621
[TBL] [Abstract][Full Text] [Related]
3. [Intestinal fatty acid binding protein: marker of enterocyte damage in acute and chronic gastroenterological diseases].
Kocsis D; Papp M; Tornai T; Tulassay Z; Herszényi L; Tóth M; Juhász M
Orv Hetil; 2016 Jan; 157(2):59-64. PubMed ID: 26726140
[TBL] [Abstract][Full Text] [Related]
4. IgA anti-tissue transglutaminase antibodies, first line in the diagnosis of celiac disease.
Samaşca G; Iancu M; Farcău D; Butnariu A; Pop T; Pîrvan A; Andreica M; Miu N; Cristea V; Dejica D
Clin Lab; 2011; 57(9-10):695-701. PubMed ID: 22029184
[TBL] [Abstract][Full Text] [Related]
5. Intestinal-FABP and liver-FABP: Novel markers for severe abdominal injury.
Relja B; Szermutzky M; Henrich D; Maier M; de Haan JJ; Lubbers T; Buurman WA; Marzi I
Acad Emerg Med; 2010 Jul; 17(7):729-35. PubMed ID: 20653587
[TBL] [Abstract][Full Text] [Related]
6. Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio.
Jin J; Peng DQ; Yuan SG; Zhao SP; Ning XH; Wang SH; Li SL
Clin Chim Acta; 2010 Nov; 411(21-22):1761-5. PubMed ID: 20688054
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum intestinal fatty acid-binding protein in full-term infants with necrotizing enterocolitis].
Huang-Fu CR; Li P; Tian YF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1125-8. PubMed ID: 25406557
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome.
Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Ducassé JL; Bottela JM; Lauque D
Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705
[TBL] [Abstract][Full Text] [Related]
9. Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome.
Park SY; Kim MH; Kim OJ; Ahn HJ; Song JY; Jeong JY; Oh SH
Clin Neurol Neurosurg; 2013 Apr; 115(4):405-10. PubMed ID: 22766253
[TBL] [Abstract][Full Text] [Related]
10. Utilizing HDL levels to improve detection of celiac disease in patients with iron deficiency anemia.
Abu Daya H; Lebwohl B; Smukalla S; Lewis SK; Green PH
Am J Gastroenterol; 2014 May; 109(5):769-70. PubMed ID: 24797006
[No Abstract] [Full Text] [Related]
11. [The value of serum intestinal fatty acid binding protein measurement in discriminating intestinal ischemia in patients with acute abdomen].
Shi H; Wu BY; Liu WH; Su BB; Li TT
Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):690-3. PubMed ID: 23158918
[TBL] [Abstract][Full Text] [Related]
12. Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects.
Ruíz-Ortiz E; Santos AL; Pujol-Autonell I; Planas R; Montraveta M; Pintos G; Doladé M; Cabré E; Vives-Pi M
Biomarkers; 2013 Mar; 18(2):178-80. PubMed ID: 23312007
[TBL] [Abstract][Full Text] [Related]
13. Magneto immunofluorescence assay for diagnosis of celiac disease.
Kergaravat SV; Beltramino L; Garnero N; Trotta L; Wagener M; Fabiano SN; Pividori MI; Hernandez SR
Anal Chim Acta; 2013 Oct; 798():89-96. PubMed ID: 24070488
[TBL] [Abstract][Full Text] [Related]
14. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
[TBL] [Abstract][Full Text] [Related]
15. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
16. Serum antibodies in celiac disease.
Dieterich W; Storch WB; Schuppan D
Clin Lab; 2000; 46(7-8):361-4. PubMed ID: 10934583
[TBL] [Abstract][Full Text] [Related]
17. Comparison of assays for anti-endomysial and anti-transglutaminase antibodies for diagnosis of pediatric celiac disease.
Levine A; Bujanover Y; Reif S; Gass S; Vardinon N; Reifen R; Lehmann D
Isr Med Assoc J; 2000 Feb; 2(2):122-5. PubMed ID: 10804933
[TBL] [Abstract][Full Text] [Related]
18. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP.
Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA
J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
20. [Heart-type fatty acid-binding protein detection for early diagnosis of acute coronary syndrome].
Zhang P; Wang Q; Zheng L; Zeng FY; Qiu YR
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):358-60. PubMed ID: 16546748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
